UNDERSTANDING THE UTILITY VALUE OF PATIENTS WITH HEAVILY PRE-TREATED MULTIPLE MYELOMA

被引：0
|
作者：
Hadi, M. [1 ]
Swinburn, P. [1 ]
de Freitas, H. M. [1 ]
Ito, T. [2 ]
机构：
[1] Mapi Grp, London, England
[2] Janssen Hlth Econ & Market Access EMEA, High Wycombe, Bucks, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.242
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM175
引用
收藏
页码：A389 / A389
页数：1
相关论文
共 50 条
  • [21] Pegfilgrastim vs. Filgrastim in the Supportive Care of Heavily Pre-Treated Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S311 - S312
  • [22] Mezigdomide (CC-92480) activates innate and adaptive immune populations in the bone marrow microenvironment of heavily pre-treated multiple myeloma patients
    Chen, Lucia
    Amatangelo, Michael
    van Oekelen, Oliver
    Upadhyaya, Bhaskar
    Lagana, Alessandro
    Kelly, Geoffrey
    Kim-Schulze, Seunghee
    Aleman, Adolfo
    Chow, Tracy
    Kurtova, Antonina
    Gandhi, Anita
    Gooding, Sarah
    Jagannath, Sundar
    Thakurta, Anjan
    Flynt, Erin
    Oppermann, Udo
    Parekh, Samir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S250 - S250
  • [23] Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients
    Musto, Pellegrino
    Fraticelli, Vincenzo Ludovico
    Mansueto, Giovanna
    D'Arena, Giovanni
    Petrilli, Maria Pia
    Gasbarrino, Cristiana
    Farina, Giuliana
    Guariglia, Roberto
    Martorelli, Maria Carmen
    Villani, Oreste
    Pietrantuono, Giuseppe
    Catalano, Lucio
    Madonna, Emanuela
    Nozza, Andrea
    Andriani, Alessandro
    Montefusco, Vittorio
    Mussetti, Alberto
    Lipari, Maria Grazia
    Ballanti, Stelvio
    Bongarzoni, Velia
    Tamiazzo, Stefania
    Patriarca, Francesca
    Vincelli, Donatella
    Falcone, Antonietta
    Derudas, Daniele
    Califano, Catello
    Zambello, Renato
    Mele, Giuseppe
    Fragasso, Alberto
    Baldini, Luca
    Palumbo, Antonio
    Storti, Sergio
    BLOOD, 2012, 120 (21)
  • [24] PREVALENT COMORBIDITIES AND DISEASE-RELATED CONDITIONS IN HEAVILY PRE-TREATED PATIENTS WITH MULTIPLE MYELOMA: A REAL-WORLD RETROSPECTIVE DATABASE ANALYSIS
    Giri, S.
    Lin, D.
    Dixon, R.
    Kim, N.
    Fowler, J.
    Barron, J.
    Tan, H.
    Nguyen, C.
    Asefaha, F.
    Vojjala, S.
    Min, E.
    Wu, B.
    VALUE IN HEALTH, 2024, 27 (06) : S174 - S174
  • [25] Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer
    Larsen, Finn Ole
    Boisen, Mogens Karsbol
    Fromm, Annelene L.
    Jensen, Benny Vittrup
    ACTA ONCOLOGICA, 2012, 51 (02) : 231 - 233
  • [26] Electrochemotherapy with intravenous bleomycin for heavily pre-treated vulvar cancer patients
    Perrone, Anna Myriam
    Corrado, Giacomo
    Coada, Camelia Alexandra
    Garganese, Giorgia
    Fragomeni, Simona Maria
    Tagliaferri, Luca
    Di Costanzo, Stella
    De Crescenzo, Eugenia
    Morganti, Alessio Giuseppe
    Ferioli, Martina
    De Terlizzi, Francesca
    Scambia, Giovanni
    De Iaco, Pierandrea
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (04) : 473 - 481
  • [27] Unusual transformations in heavily pre-treated patients receiving fludarabine.
    Byrd, JC
    Shields, DS
    Dow, NS
    Burrell, L
    Aguilera, NS
    Abbondanzo, SL
    Diehl, LF
    BLOOD, 1996, 88 (10) : 3580 - 3580
  • [28] Adjusted Comparisons Suggest Daratumumab Is Associated with Prolonged Survival Compared with Standard of Care Therapies in Patients with Heavily Pre-Treated and Highly Refractory Multiple Myeloma
    Kumar, Shaji K.
    Durie, Brian G. M.
    Su, Zhuo
    Diels, Joris
    Hutton, Brian
    Lam, Annette
    Tetsuro, Ito
    BLOOD, 2016, 128 (22)
  • [29] Carfilzomib-Based Regimens Are Efficacious and Well Tolerated in Heavily Pre-Treated Multiple Myeloma Patients: Real World Data from a Norwegian Cohort
    Lysen, Anna
    Haarstad, Ina
    Schjesvold, Fredrik H.
    BLOOD, 2018, 132
  • [30] TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
    Lynge, M.
    Liposits, G. I.
    Linnet, S.
    Langkjer, S. T.
    BREAST, 2013, 22 : S43 - S43
12345